National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/19/2021 release of VAERS data:

Found 19,249 cases where Vaccine targets COVID-19 (COVID19) and Patient Died

Government Disclaimer on use of this data



Case Details

This is page 1275 out of 1,925

Result pages: prev   1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284   next


VAERS ID: 1338069 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-04-27
Onset:2021-05-10
   Days after vaccination:13
Submitted: 0000-00-00
Entered: 2021-05-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Sudden death
SMQs:, Torsade de pointes/QT prolongation (broad), Arrhythmia related investigations, signs and symptoms (broad), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-10
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Non-smoker
Allergies:
Diagnostic Lab Data:
CDC Split Type: ESPFIZER INC2021553656

Write-up: Sudden death; This is a spontaneous report from a contactable consumer or other non hcp downloaded from the regulatory authority, ES-AEMPS-861158. A 64-year-old male patient received BNT162b2 (COMIRNATY, Solution for injection, Lot number- UNKNOWN) via an unspecified route of administration in arm on 27Apr2021 as 1st dose single for COVID-19 immunization. Patient medical history included that the patient had no known pathologies and was a non-smoker, athlete and concomitant medications were not reported. A family member reported that the patient had not been infected by COVID-19. On 10May2021 (as reported) Death occurred at night, two weeks after vaccination. It was classified as cardiorespiratory arrest. The judge has denied the autopsy request, despite the fact that the family doctor requested it, on suspicion that vaccination may have played some role in the outcome. The outcome of the event was fatal. No follow-up attempts are possible, information on batch number cannot be obtained.; Reported Cause(s) of Death: Cardio-respiratory arrest


VAERS ID: 1338072 (history)  
Form: Version 2.0  
Age: 83.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-04-30
Onset:2021-04-30
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-05-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EY3014 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Body temperature, Chills, Cough, Musculoskeletal pain, Pneumonia, Pyrexia, SARS-CoV-2 test, SARS-CoV-2 test positive, Sneezing
SMQs:, Rhabdomyolysis/myopathy (broad), Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Eosinophilic pneumonia (broad), Hypersensitivity (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (narrow), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-12
   Days after onset: 12
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Celiac disease; Chronic kidney disease; Dyslipidaemia; Gastrooesophageal reflux; Hypertension arterial; Hypoacusis; Ischaemic heart disease; Obesity (BMI 33); Sleep apnea
Allergies:
Diagnostic Lab Data: Test Date: 20210503; Test Name: body temperature; Result Unstructured Data: Test Result:38.5 Centigrade; Test Date: 20210503; Test Name: body temperature; Result Unstructured Data: Test Result:38.7 Centigrade; Test Date: 20210506; Test Name: COVID-19 PCR test; Test Result: Positive
CDC Split Type: ESPFIZER INC2021559947

Write-up: bilateral pneumonia; covid-positive pcr; 38,5?C, 38,7?C; Shivering; Cough; Sneezing; Arthromyalgia; This is a spontaneous report from a contactable physician downloaded from a regulatory authority-WEB ES-AEMPS-863640. A 83-year-old male patient received bnt162b2 (COMIRNATY), dose 1 intramuscular on 30Apr2021 (Lot Number: EY3014) as SINGLE DOSE for covid-19 immunisation. Medical history included hypertension arterial, sleep apnea, obesity, chronic kidney disease, celiac disease, hypoacusis, gastrooesophageal reflux, ischaemic heart disease, dyslipidaemia. The patient''s concomitant medications were not reported. The patient experienced cough (death, hospitalization, medically significant) on 30Apr2021, sneezing (death, hospitalization, medically significant) on 30Apr2021, arthromyalgia (death, hospitalization, medically significant) on 30Apr2021, shivering (death, hospitalization, medically significant) on 01May2021, 38,5?c, 38,7?c (death, hospitalization, medically significant) on 03May2021, bilateral pneumonia (death, hospitalization, medically significant) on 06May2021, covid-positive pcr (death, hospitalization, medically significant) on 06May2021. The patient died on 12May2021. It was not reported if an autopsy was performed. Treatment included solumoderin + nolotil 575mg + paracetamol 1000mg + pectoxlisine + oxygen + dexamethasone + ethylprednisolone + ceftriaxone + hbpm. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: bilateral pneumonia; covid-positive pcr; Shivering; Cough; Sneezing; Arthromyalgia; 38,5?C, 38,7?C


VAERS ID: 1338074 (history)  
Form: Version 2.0  
Age: 90.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-10
Onset:2021-01-10
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-05-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EM0477 / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Blood pressure measurement, Death, Dizziness, Hypertension
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Hypertension (narrow), Vestibular disorders (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-11
   Days after onset: 120
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Angiopathy; Chronic kidney disease
Allergies:
Diagnostic Lab Data: Test Name: blood pressure; Result Unstructured Data: Test Result:180/80
CDC Split Type: ESPFIZER INC2021559964

Write-up: unknown cause of death; Hypertension; Dizziness; This is a spontaneous report from a contactable other healthcare professional downloaded from the regulatory authority ES-AEMPS-864516. A 90-year-old male patient received bnt162b2 (COMIRNATY) intramuscular on 10Jan2021 (Batch/Lot Number: EM0477) as 0.3ml single for COVID-19 immunisation. Medical history included chronic kidney disease and peripheral angiopathy. The patient''s concomitant medications were not reported. The patient experienced hypertension (death) on 10Jan2021, dizziness (death) on 10Jan2021, unknown cause of death on 11May2021. The patient underwent lab tests and procedures which included blood pressure: 180/80 on an unknown date. The patient died on 11May2021. It was not reported if an autopsy was performed. The clinical course was reported as follows: Exitus a few hours after receiving the vaccine. It started with dizziness and blood pressure elevation. Additional information obtained: Urgent assistance report on 11Jan2021 at 19:51. Patient of bad general state, hypertension 180/80 without vegetatism. Treatment: sublingual amlodipine. History of chronic kidney disease and peripheral angiopathy. It was impossible to obtain data of the exitus. Outcome of the events was fatal. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Hypertension; Dizziness; unknown cause of death


VAERS ID: 1338075 (history)  
Form: Version 2.0  
Age: 79.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-02-19
Onset:2021-02-19
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-05-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EM6950 / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Aspiration, Asthenia, Diarrhoea, General physical health deterioration, Presyncope, Pyrexia, Vomiting
SMQs:, Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Pseudomembranous colitis (broad), Guillain-Barre syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hypotonic-hyporesponsive episode (broad), Noninfectious diarrhoea (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-21
   Days after onset: 2
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Aspiration pneumonia (From the 18 to 24Jan2021 admission for bronchoaspiration pneumonia); Chronic kidney disease; Chronic obstructive pulmonary disease; Diabetes mellitus; Dyslipidemia; Hypertension; Hypothyroidism; Vascular dementia
Allergies:
Diagnostic Lab Data:
CDC Split Type: ESPFIZER INC2021560627

Write-up: Vomiting; low-grade fever; weakness; sudden worsening of the general condition; bronchoaspiration/Aspiration into bronchus; Diarrhoea; a self-limiting vagal reaction; This is a spontaneous report downloaded from the Regulatory Authority (RA)-WEB [ES-AEMPS-864584]. This contactable other HCP reported events for both doses of Comirnaty for this patient. This is the first of two reports for the second dose. A 79-year-old male patient received bnt162b2 (COMIRNATY), intramuscular on 19Feb2021 (Lot Number: EM6950) as 2nd dose, 0.3ml single for covid-19 immunisation. Medical history included hypertension, diabetes mellitus, dyslipidemia, vascular dementia, chronic kidney disease, chronic obstructive pulmonary disease, hypothyroidism; From the 18 to 24Jan2021 admission for bronchoaspiration pneumonia. The patient''s concomitant medications were not reported. The patient previously received bnt162b2 (COMIRNATY), intramuscular on 28Jan2021 (Lot Number: EJ6796) as 1st dose single for covid-19 immunization and experienced the fever that was not measured, from 03Feb2021 to 18Feb2021 new admission with acute respiratory failure with aspiration. Received a second dose of vaccine on 19Feb2021 and 2 hours later presented with diarrhea with a self-limiting vagal reaction. On 21Feb2021 started to have low-grade fever, weakness, a sudden worsening of the general condition, vomiting, diarrhea, and died. It is oriented as probable bronchoaspiration/Aspiration into bronchus. The outcome of the events was fatal. The patient died on 21Feb2021 due to events. It was not reported if an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Sender''s Comments: Linked Report(s) : ES-PFIZER INC-2021573951 the same patient different dose of product; Reported Cause(s) of Death: Diarrhoea; a self-limiting vagal reaction; Vomiting; low-grade fever; weakness; sudden worsening of the general condition; Aspiration into bronchus


VAERS ID: 1338084 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-03-17
Onset:2021-04-18
   Days after vaccination:32
Submitted: 0000-00-00
Entered: 2021-05-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ET3620 / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: AST/ALT ratio abnormal, Auscultation, Base excess, Blood bicarbonate, Blood calcium, Blood creatinine, Blood creatinine decreased, Blood fibrinogen, Blood fibrinogen increased, Blood glucose, Blood glucose increased, Blood lactic acid, Blood lactic acid increased, Blood potassium, Blood pressure diastolic, Blood pressure increased, Blood pressure systolic, Blood sodium, Blood urea, Blood urea increased, Body temperature, Body temperature decreased, Cardio-respiratory arrest, Chest X-ray, Electrocardiogram, Haematocrit, Haematocrit decreased, Haemoglobin, Heart rate, International normalised ratio, International normalised ratio increased, Lymphocyte count, Lymphocyte count decreased, Mean cell volume, Neutrophil count, Oxygen saturation, PCO2, PCO2 increased, Percussion test, Platelet count, Platelet count decreased, Protein total, Respiratory rate, SARS-CoV-2 test, Transaminases, White blood cell count, White blood cell count increased, pH body fluid
SMQs:, Torsade de pointes/QT prolongation (broad), Acute renal failure (broad), Liver related investigations, signs and symptoms (narrow), Liver-related coagulation and bleeding disturbances (narrow), Anaphylactic reaction (broad), Haematopoietic erythropenia (broad), Haematopoietic leukopenia (narrow), Haematopoietic thrombocytopenia (narrow), Lactic acidosis (narrow), Haemorrhage laboratory terms (broad), Hyperglycaemia/new onset diabetes mellitus (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Arrhythmia related investigations, signs and symptoms (broad), Retroperitoneal fibrosis (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (broad), Hypertension (narrow), Chronic kidney disease (broad), Tumour lysis syndrome (broad), Respiratory failure (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-18
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: METFORMIN; PARACETAMOL; SINEMET; TAMSULOSIN; XARELTO; MEMANTINE
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Atrial fibrillation; Dementia; Ex-smoker; Hematuria; Parkinson''s disease (Predominant motor clinical picture, significant walking limitation); Tumor; Type 2 diabetes mellitus; Walking difficulty
Allergies:
Diagnostic Lab Data: Test Name: Cardiac auscultation; Result Unstructured Data: Test Result:without audible murmurs; Comments: arrhythmic heart tones without audible murmurs, pitting bi-malleolar edema; Test Name: Respiratory auscultation; Result Unstructured Data: Test Result:wheezing; Comments: wheezing and rhonchi disseminated with bi-basal crackles; Test Name: excess base; Result Unstructured Data: Test Result:4.8; Test Name: bicarbonate; Result Unstructured Data: Test Result:-30.3; Test Name: calcium; Test Result: 9.4 mg/dl; Test Name: creatinine; Test Result: 0.57 mg/dl; Test Name: fibrinogen; Result Unstructured Data: Test Result:4.79; Test Name: glucose; Test Result: 162 mg/dl; Test Name: lactates; Result Unstructured Data: Test Result:2.2; Test Name: potassium; Result Unstructured Data: Test Result:3.79 mmol/L; Test Name: Diastolic blood pressure; Result Unstructured Data: Test Result:80 mmHg; Test Name: Systolic blood pressure; Result Unstructured Data: Test Result:152 mmHg; Test Name: sodium; Result Unstructured Data: Test Result:143.5 mmol/L; Test Name: urea; Test Result: 56 mg/dl; Test Name: Axillary temperature; Result Unstructured Data: Test Result:35.8 Centigrade; Comments: decreased; Test Name: Chest X-ray; Result Unstructured Data: Test Result:Signs of vascular redistribution; Comments: Signs of vascular redistribution, without clear condensations; Test Name: Electrocardiogram; Result Unstructured Data: Test Result:without acute alterations in repolarization; Comments: Atrial fibrillation at 60 beats/minute, axis at 30?, narrow QRS, without acute alterations in repolarization; Test Name: Hematocrit; Test Result: 38.6 %; Test Name: Hemoglobin; Result Unstructured Data: Test Result:12.1 g/dl; Test Name: heart rate; Result Unstructured Data: Test Result:102 beats per minute; Test Name: international normalized ratio; Result Unstructured Data: Test Result:3.32; Test Name: lymphocyte count; Result Unstructured Data: Test Result:600; Test Name: mean corpuscular volume; Result Unstructured Data: Test Result:95.8 fL; Test Name: neutrophil count; Result Unstructured Data: Test Result:9800; Test Name: Oxygen saturation; Test Result: 100 %; Comments: 100.00% (with ventimask oxygen requirement)), after 69% in ambient air; Test Name: partial pressure of carbon dioxide; Result Unstructured Data: Test Result:50; Test Name: fist percussion test; Test Result: Negative ; Test Name: pH; Result Unstructured Data: Test Result:7.39; Test Name: platelets; Result Unstructured Data: Test Result:115000; Test Name: protein; Result Unstructured Data: Test Result:7.2; Test Name: respiration rate; Result Unstructured Data: Test Result:20 per minute; Test Date: 20210318; Test Name: SARS-CoV-2 polymerase chain reaction; Test Result: Negative ; Test Name: aspartate transaminase/alanine aminotransferase; Result Unstructured Data: Test Result:23/8 IU/l; Test Name: leukocytes; Result Unstructured Data: Test Result:11630
CDC Split Type: ESPFIZER INC2021566934

Write-up: Hematocrit 38.6%; leukocytes: 11630; lymphocyte count: 600; platelets 115000; international normalized ratio 3.32; fibrinogen 4.79; glucose 162 mg/dL; Urea 56 mg/dL; aspartate transaminase/alanine aminotransferase 23/8 IU/L; creatinine 0.57 mg/dL; partial pressure of carbon dioxide 50; lactates 2.2; Axillary temperature: 35.8 Centigrade; Systolic blood pressure 152 mmHg,Diastolic blood pressure 80 mmHg; Cardiorespiratory arrest; This is a spontaneous report from a contactable physician. This is the second of two reports. The first report is a report downloaded from the Regulatory Authority. An 85-year-old male patient received second dose of BNT162B2 (COMIRNATY, Solution for injection, Lot Number: ET3620), intramuscular on 17Mar2021 (at unknown age) as 0.3ml single for COVID-19 immunisation. Medical history included Ex-smoker, Type 2 diabetes mellitus, Atrial fibrillation, Vesical tumor, episodes of gross hematuria, Parkinson (Predominant motor clinical picture, significant walking limitation), Moderate-severe dementia, walking difficulty. Concomitant medications included metformin; paracetamol; carbidopa, levodopa (SINEMET); tamsulosin; rivaroxaban (XARELTO); memantine. The patient previously took first dose of BNT162B2 (COMIRNATY, batch/lot number: EP9598) on 22Feb2021, intramuscular at single dose for COVID-19 immunisation and had Respiratory failure. The patient underwent lab tests and procedures which included on unknown date: Cardiac auscultation: arrhythmic heart tones without audible murmurs, pitting bi-malleolar edema, Respiratory auscultation: wheezing and rhonchi disseminated with bi-basal crackles, excess base: 4.8, bicarbonate: -30.3, calcium: 9.4 mg/dl, creatinine: 0.57 mg/dl, fibrinogen: 4.79, glucose: 162mg/dl, lactates:2.2, potassium: 3.79mmol/l, Diastolic blood pressure: 80 mmHg, Systolic blood pressure: 152 mmHg, sodium: 143.5, urea: 56 mg/dl, Axillary temperature: 35.8 Centigrade, Chest X-ray: Signs of vascular redistribution, without clear condensations, Electrocardiogram: without acute alterations in repolarization Atrial fibrillation at 60 beats/minute, axis at 30?, narrow QRS, without acute alterations in repolarization, Hematocrit: 38.6%, Hemoglobin: 12.1 g/dl, heart rate: 102 beats per minute, international normalized ratio: 3.32, lymphocyte count: 600, mean corpuscular volume: 95.8 fL, neutrophil count: 9800, Oxygen saturation: 100.00% (with ventimask oxygen requirement)), after 69% in ambient air, partial pressure of carbon dioxide: 50, fist percussion test: negative, pH: 7.39, platelets: 115000, protein: 7.2, respiration rate: 20 per minute, aspartate transaminase/alanine aminotransferase: 23/8 iu/l, leukocytes: 11630; on 18Mar2021, SARS-CoV-2 polymerase chain reaction: negative. The patient had Cardio-respiratory arrest on 18Apr2021, and passed away on 18Apr2021. It was unknown if an autopsy was performed. The outcome of Cardiorespiratory arrest was fatal, for other events was unknown. No follow-up attempts possible. No further information expected.; Sender''s Comments: Linked Report(s) : ES-PFIZER INC-2021553698 same patient, different vaccine doses; Reported Cause(s) of Death: Cardiorespiratory arrest


VAERS ID: 1338179 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-27
Onset:2021-01-29
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-05-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EK9788 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Apnoea, Dyspnoea
SMQs:, Anaphylactic reaction (broad), Acute central respiratory depression (narrow), Pulmonary hypertension (broad), Cardiomyopathy (broad), Respiratory failure (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-03
   Days after onset: 5
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: MIRTAZAPINE; ASTECON; PANADOL FORTE; MATRIFEN; VISCOTEARS; FURESIS; KALCIPOS-D; BISOPROLOL FUMARATE; PEGORION; KETIPINOR; VENTOLINE; ELIQUIS; SERETIDE DISKUS
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Alzheimer''s disease (G30.1 Late-onset); Asthma, unspecified (J45.9); Atherosclerotic cardiovascular disease (I25.1); Constipation; Depression; Dry eye; Heart disease, unspecified (a pre-existing heart disease); Hypercholesterolemia (E78.0); Ischaemia (I25.9); Oedema peripheral; Osteoporosis; Pain
Allergies:
Diagnostic Lab Data:
CDC Split Type: FIPFIZER INC2021553658

Write-up: Apnoea; Dyspnoea; This is a spontaneous report from a contactable nurse, from the regulatory authority, downloaded from the regulatory authority-WEB. The regulatory authority report number is FI-FIMEA-20212456. An 86-year-old female patient received the first dose of BNT162B2 (COMIRNATY, lot number: EK9788) via intramuscular on 27Jan2021 (unknown age at time of vaccination), at single dose, for COVID-19 immunization. The patient''s medical history included (G30.1 Late-onset) Alzheimer''s disease, (I25.1) atherosclerotic essential RR disease, (J45.9) unspecified asthma, (E78.0) hypercholesterolemia, (I25.9) unspecified ischaemia, a pre-existing heart disease, depression, pain, dry eye, oedema peripheral, osteoporosis, and constipation. Concomitant medications included mirtazapine taken for depression; montelukast sodium (ASTECON) taken for asthma; paracetamol (PANADOL FORTE); fentanyl (MATRIFEN) taken for pain; carbomer (VISCOTEARS) taken for dry eye; furosemide (FURESIS) taken for oedema peripheral; calcium carbonate/colecalciferol (KALCIPOS-D) taken for osteoporosis; bisoprolol fumarate; macrogol 4000 (PEGORION) taken for constipation; quetiapine fumarate (KETIPINOR); salbutamol (VENTOLINE) taken for asthma; apixaban (ELIQUIS); fluticasone propionate/salmeterol xinafoate (SERETIDE DISKUS) taken for asthma. The patient experienced apnoea and dyspnoea on 29Jan2021 (2 days after vaccination). 07May2021, nurse reported: "The patient was in a long-term care home for Alzheimer''s disease. Two days after receiving the vaccine, shortness of breath while resting and shortness of breath started. The patient died on 03Feb2021. I made this announcement together with other close relatives, based on information from the place of care." The outcome of the events apnoea and dyspnoea was fatal. It was unknown whether an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Apnoea; Dyspnoea


VAERS ID: 1338187 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-04-15
Onset:2021-04-17
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-05-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW2246 / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Body temperature, Death, General physical health deterioration, Pyrexia
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-27
   Days after onset: 10
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: PAMOL; RISPERDAL
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Asthma; Dementia NOS; Osteoarthritis
Allergies:
Diagnostic Lab Data: Test Date: 202104; Test Name: body temperature; Result Unstructured Data: Test Result:over 38.0 Centigrade; Comments: 17-19Apr2021 fever over 38.0 degrees; Test Date: 202104; Test Name: body temperature; Result Unstructured Data: Test Result:37.2 - 37.4 Centigrade; Comments: 20-26Apr2021 mild warming (37.2 - 37.4. Degrees)
CDC Split Type: FIPFIZER INC2021560871

Write-up: Exitus; recent fading of the well-being; fever; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority-WEB, regulatory authority number FI-FIMEA-20212573. A 92-years-old female patient received bnt162b2 (COMIRNATY), dose 2 intramuscular on 15Apr2021 (Batch/Lot Number: EW2246) as single dose for covid-19 immunisation. Medical history included asthma, osteoarthritis, unspecified dementia. No known allergies. Concomitant medications included paracetamol (PAMOL) taken for an unspecified indication, start and stop date were not reported; risperidone (RISPERDAL) taken for an unspecified indication, start and stop date were not reported. The patient previously received first dose of bnt162b2 for covid-19 immunization with no side effects. 17-19Apr2021 fever over 38.0 degrees without changes in inflammatory values or other symptoms of infection. No detectable infection focus. 20-26Apr2021 mild warming (37.2 - 37.4 Degrees) and recent fading of the well-being. Hospice decision 26Apr2021. Exitus 27Apr2021. Prolonged fever after COVID 19 vaccine without evidence of infection. The outcome of the events fever and ''fading of the well-being'' was unknown. The patient died on 27Apr2021. It was unknown if an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Exitus


VAERS ID: 1338191 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-02-16
Onset:2021-04-01
   Days after vaccination:44
Submitted: 0000-00-00
Entered: 2021-05-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER0641 / 2 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Dyspnoea, Pyrexia, SARS-CoV-2 test, Vaccination failure
SMQs:, Anaphylactic reaction (broad), Lack of efficacy/effect (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-14
   Days after onset: 13
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: COVID-19; Fibrosis pulmonary
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210401; Test Name: SARS-CoV-2 test; Test Result: Positive ; Comments: tested positive for the specific countries variant
CDC Split Type: FRPFIZER INC2021553671

Write-up: dyspnoea; fever; Vaccination failure/tested positive for the specific countries variant; COVID-19/tested positive for the specific countries variant; This is a spontaneous report from a contactable other health professional downloaded from a regulatory authority-WEB, regulatory authority number FR-AFSSAPS-2021050910. A 95-year-old female patient received BNT162B2 (COMIRNATY), 1st dose intramuscularly, administered in arm left on 26Jan2021 (Lot Number: EM0477) as a single dose, 2nd dose intramuscularly, administered in arm left on 16Feb2021 (Lot Number: ER0641) as a single dose for COVID-19 immunisation. Medical history included ongoing COVID-19 (as reported), ongoing fibrosis pulmonary. The patient''s concomitant medications were not reported. The patient experienced vaccination failure/tested positive for the specific countries variant, COVID-19/tested positive for the specific countries variant, both on 01Apr2021 and the events were reported as death, dyspnoea and fever, both on 11Apr2021, and the events were reported as being hospitalization and death. The patient was tested positive for the specific countries variant on 01Apr2021, hospitalized on 11Apr2021 for fever and dyspnoea, death on 14Apr2021. The patient underwent lab tests and procedures which included SARS-CoV-2 test: positive (tested positive for the specific countries variant) on 01Apr2021. The patient died on 14Apr2021. An autopsy was not performed. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Vaccination failure/tested positive for the specific countries variant; dyspnoea; fever; COVID-19/tested positive for the specific countries variant


VAERS ID: 1338194 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-04-19
Onset:2021-05-06
   Days after vaccination:17
Submitted: 0000-00-00
Entered: 2021-05-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW2246 / 2 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Activated partial thromboplastin time, Angiogram, Blood gases, Blood pressure measurement, Blood test, Body temperature, Coma scale, Echocardiogram, Fraction of inspired oxygen, Glomerular filtration rate, Heart rate, Ischaemic stroke, Neurological examination, Oxygen saturation, Platelet count, Prothrombin time, Pulmonary embolism, Respiratory rate, Visual analogue scale, White blood cell count
SMQs:, Ischaemic central nervous system vascular conditions (narrow), Embolic and thrombotic events, arterial (narrow), Embolic and thrombotic events, venous (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-07
   Days after onset: 1
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: ESOMEPRAZOLE; DILTIAZEM; BISOPROLOL; HYDROCHLOROTHIAZIDE; RAMIPRIL; METFORMIN; TRAMADOL; PARACETAMOL
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Cognitive disorder; Hypertension arterial; Iron deficiency anaemia (Regenerative iron deficiency anaemia); Reflux esophagitis; Type 2 diabetes mellitus
Allergies:
Diagnostic Lab Data: Test Date: 20210506; Test Name: activated partial thromboplastin time; Result Unstructured Data: Test Result:0.8; Test Date: 20210506; Test Name: computed tomography angiography; Result Unstructured Data: Test Result:pulmonary embolism; Comments: multiple endovascular lacunar images compatible with right middle and lower lobar pulmonary embolism.; Test Date: 20210507; Test Name: computed tomography angiography; Result Unstructured Data: Test Result:ischemic stroke; Comments: large right parietal-occipital hypodensity indicating an ischemic stroke. No cerebral haemorrhage. No mass effect or parenchymal expansive process. Ventricular system, cortical sulci and basal cisterns are unremarkable. Vasculodegenerative leukopathy.; Test Date: 20210506; Test Name: gazometry; Result Unstructured Data: Test Result:hypoxia-hypocapnia; Comments: suggesting a pulmonary embolism, although the calves are supple and not painful; Test Date: 20210507; Test Name: gazometry; Result Unstructured Data: Test Result:acidosis; Comments: catastrophic with significant acidosis.; Test Date: 20210506; Test Name: blood pressure; Result Unstructured Data: Test Result:133/77 mmHg; Test Date: 20210507; Test Name: blood pressure; Result Unstructured Data: Test Result:60/40 mmHg; Test Date: 20210506; Test Name: blood panel; Result Unstructured Data: Test Result:anaemia; Comments: probably related to the oesophageal pathology; Test Date: 20210506; Test Name: body temperature; Result Unstructured Data: Test Result:35,7 Centigrade; Test Date: 20210507; Test Name: body temperature; Result Unstructured Data: Test Result:35,7 Centigrade; Test Date: 20210506; Test Name: Glasgow Coma Scale; Result Unstructured Data: Test Result:15; Comments: 15 despite spatial-temporal disorientation; Test Date: 20210507; Test Name: Glasgow Coma Scale; Result Unstructured Data: Test Result:3; Test Date: 20210507; Test Name: cardiac echocardiogram; Result Unstructured Data: Test Result:no right or left myocardial failure; Test Date: 20210507; Test Name: fio2; Test Result: 84 %; Test Date: 20210506; Test Name: mdrd gfr; Test Result: 56 mL; Comments: moderate renal insufficiency; Test Date: 20210506; Test Name: heart rate; Result Unstructured Data: Test Result:128; Comments: /minute; Test Date: 20210506; Test Name: heart rate; Result Unstructured Data: Test Result:90; Comments: /minute; Test Date: 20210507; Test Name: heart rate; Result Unstructured Data: Test Result:94; Test Date: 20210506; Test Name: neurological examination; Result Unstructured Data: Test Result:no signs of localisation; Test Date: 20210506; Test Name: oxygen saturation; Test Result: 99 %; Comments: saturated oxygen 99% in ambient air; Test Date: 20210507; Test Name: oxygen saturation; Test Result: 85 %; Test Date: 20210507; Test Name: oxygen saturation; Test Result: 80 %; Comments: the respiratory insufficiency worsens at 80% in ambient air; Test Date: 20210506; Test Name: platelets; Result Unstructured Data: Test Result:387 g/l; Comments: normal; Test Date: 20210507; Test Name: platelets; Result Unstructured Data: Test Result:386 g/l; Test Date: 20210506; Test Name: prothrombin time; Test Result: 70 %; Test Date: 20210506; Test Name: respiration rate; Result Unstructured Data: Test Result:28; Comments: 28/minute; Test Date: 20210507; Test Name: respiration rate; Result Unstructured Data: Test Result:28; Comments: /minute; Test Date: 20210507; Test Name: Visual Analogue Scale; Result Unstructured Data: Test Result:15; Test Date: 20210506; Test Name: leukocytes; Result Unstructured Data: Test Result:19.8 g/l
CDC Split Type: FRPFIZER INC2021553629

Write-up: Ischemic stroke; Embolism pulmonary; This is a spontaneous report from a contactable physician downloaded from a regulatory authority-WEB, regulatory authority number FR-AFSSAPS-2021052029. A 78-years-old male patient received second dose of bnt162b2 (COMIRNATY), intramuscular, administered in Arm Left on 19Apr2021 (Lot Number: EW2246) as 2nd dose, single for covid-19 immunisation. Medical history included Early cognitive disorders, Type 2 diabetes mellitus, Hypertension arterial, Reflux esophagitis, Regenerative iron deficiency anaemia. No COVID HISTORY. Concomitant medications included esomeprazole, diltiazem, bisoprolol, hydrochlorothiazide, ramipril, metformin, tramadol, paracetamol. The patient previously received first dose of bnt162b2, on 23Mar2021 (Lot Number: ER9470) as 1st dose, single for covid-19 immunisation. 17 days after Dose 2, on 06May2021, the patient was sent to the Emergency Room by their general practitioner due to a change in their general state with dyspnoea, date of onset not provided. The clinical examination was without any significant particularity (35.7?C; 133/77mmHg; Heart rate 128/minute; saturated oxygen 99% in ambient air; respiration rate 28/minute; Glasgow Coma Scale 15 despite spatial-temporal disorientation; Glc cap. 3g/l; symmetrical vesicular murmur with no rattle, neurological examination with no signs of localisation). Heart rate slowed spontaneously to sinus rhythm at 90/minute. The blood panel revealed anaemia (probably related to the oesophageal pathology), hyperleucocytosis (19.8g/l), moderate renal insufficiency (MDRD 56ml/minute) and, above all, hypoxia-hypocapnia, suggesting a pulmonary embolism, although the calves are supple and not painful. The platelets are normal at 387g/l. Prothrombin time 70%, activated partial thromboplastin time 0.8. This hypothesis is confirmed by computed tomography angiography: multiple endovascular lacunar images compatible with right middle and lower lobar pulmonary embolism. The patient is placed on Apixaban, and admitted to hospital. The patient had a slightly agitated night (got up, fell, incoherent remarks). In the afternoon of 07May2021, (Day 18 from Dose 2), while starting an erythrocyte transfusion, the respiratory insufficiency worsens with saturated oxygen at 80% in ambient air, appearance of crepitants at mid-field (Furosemide, high concentration oxygen), increase of cognitive disorders with agitation, no hemodynamic alteration. Platelets on 07May2021: 386g/l. Upon being taken into care around 16:45: 35.7?c; 60/40mmHg ; heart rate 94/minute; saturated o2 85% on FiO2 84% ; Respiratory rate 28/minute; Glasgow Coma Scale 3; Visual Analogue Scale 15; Glc cap. 5.09g/l Conduct: non-invasive ventilation (NIV) with face mask; Noradrenalin; cardiac echocardiogram done: no right or left myocardial failure. Sudden neurological deterioration with Glasgow Coma 3, the appearance of a left mydriasis while an anticoagulant treatment had just been started: a cerebral computed tomography scan is requested. Progression:The gazometry on non-invasive ventilation is catastrophic with significant acidosis. The computed tomography scan showed a large right parietal-occipital hypodensity indicating an ischemic stroke. No cerebral haemorrhage. No mass effect or parenchymal expansive process. Ventricular system, cortical sulci and basal cisterns are unremarkable. Vasculodegenerative leukopathy. Death is recorded at 18:25 at the end of carrying out the computed tomography scan. The declarant concludes a thrombotic storm with severe pulmonary embolism then ischemic stroke despite the prescription since the day before of Apixaban in a hypertensive, type II diabetic man who had received the second injection of Comirnaty vaccine 17 days earlier. Regenerative iron deficiency anaemia which could not be investigated but probably related to oesophageal pathology on hiatus hernia (history of oesophagitis). Moderate renal insufficiency. Coma then asystole leading to death. According to the declaring resucitator, the clinical signs seemed very unusual. He suggested a hypothesis of a paradoxical embolism linked to a permeable oval foramen, but the localisation of the cerebral vascular accident does not favour this hypothesis. Further, the pulmonary embolism was not massive. Awaiting information on a possible blood sample for a thrombophilia test and anti-PF4 antibody level test (but unlikely to have been carried out in this very rapidly unfavourable context). In summary: pulmonary embolism followed by a massive ischemic stroke 17 days after the 2nd dose of COMIRNATY in a 78-year old patient, leading to his death; normal platelets, no dose of anti-PF4 antibodies." The patient died on 07May2021. An autopsy was not performed. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Embolism pulmonary; Ischemic stroke


VAERS ID: 1338202 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-04-09
Onset:2021-04-18
   Days after vaccination:9
Submitted: 0000-00-00
Entered: 2021-05-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW2246 / 2 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Sudden death
SMQs:, Torsade de pointes/QT prolongation (broad), Arrhythmia related investigations, signs and symptoms (broad), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-18
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Aortic valve disease mixed; Colon cancer; Nephrectomy; Renal carcinoma (renal carcinoma in 2002 with nephrectomy)
Allergies:
Diagnostic Lab Data:
CDC Split Type: FRPFIZER INC2021553644

Write-up: Sudden death; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB. The regulatory authority report number is [FR-AFSSAPS-BX20214353] and Safety Report Unique Identifier [FR-AFSSAPS-2021052758]. An 85-year-old male patient received BNT162B2 (COMIRNATY) (Batch/Lot Number: EW2246) via intramuscular, administered in arm left on 09Apr2021 as 2nd dose, single for covid-19 immunisation. Medical history included moderate aortic valve disease; renal carcinoma in 2002 with nephrectomy; colon cancer in 2017. The patient''s concomitant medications were not reported. Patient previously received first dose of BNT162B2 for covid-19 immunisation. On Day 9 of Dose 2 (18Apr2021), patient was found dead in the shower, although he was asymptomatic a few minutes before. The sudden death without triggering factor or cause found. Patient did not have Covid-19; he had not been tested. The patient died on 18Apr2021. It was not reported if an autopsy was performed. The reported cause of death was sudden death without triggering factor. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: sudden death without triggering factor


Result pages: prev   1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=1275&VAX=COVID19&VAXTYPES=COVID-19&DIED=Yes


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166